Search

You searched for "focus"

1311 results found

In conversation with Charles Leclercq (ARxVision)

5 October 2022 | | EYE - General
Julian Jackson (Founder and Director, VisionBridge) spoke to Charles Leclercq (CEO, ARx) about the ARxVision, a wearable device that captures the world around us through audio and artificial intelligence to empower blind and low-vision individuals. You can read the Eye...

Quality matters in the management of serious eye disorders

1 June 2019 | | EYE - Cataract, EYE - Glaucoma, EYE - Neuro-ophthalmology, EYE - Vitreo-Retinal
The author discusses the first quality standard for serious eye disorders from NICE and takes a look at new care models for enhanced service delivery. Patient backlogs pose risks to patient safety, with research showing that people are losing sight...

Strategies for fostering psychological safety in healthcare

19 August 2025 | | EYE - General | Wellbeing
Holding a degree in Ecology, an MBA, and currently pursuing a Masters in Global Health and Humanitarianism at the University of Manchester, Tom merges academic knowledge with real-world experience. His focus lies in leveraging the transformative power of psychological safety,...

Fellow eye comparison of DMEK and PKP

1 February 2014 | | EYE - Cornea, EYE - General
This retrospective analysis of 11 patients who underwent penetrating keratoplasty (PKP) in their first eye followed by descemet membrane endothelial keratoplasty (DMEK) in their second eye studied visual and refractive outcomes. Intra and postoperative complications were compared and a subjective...

Ripasudil after Descemet stripping in Fuch’s endothelial dystrophy

1 June 2019 | | EYE - Cornea, EYE - General
This study prospectively evaluated the use of ripasudil, a rho kinase inhibitor, in patients undergoing Descemet’s stripping only (DSO) without an endothelial graft for Fuch’s endothelial dystrophy (FED). Patients with dense central guttae limited to the central 5mm of the...

The Worshipful Company of Spectacle Makers awards two Master’s Medals for early career research

21 October 2025 | WCSM, early career, awards, genetics, AI
The Worshipful Company of Spectacle Makers (WCSM) this week announced the winners of two Master’s Medals for 2025. Fabian Yii from Edinburgh was awarded the Master’s Medal for his paper, 'Fundus Refraction Offset as a Personalized Biomarker for 12-Year Risk...

AOP champions member voices in new benefits video

7 November 2023 | AOP, member benefits, optometry, optometrists
The Association of Optometrists (AOP) produces a new member focused video to showcase the support the AOP provides through members’ careers.

Moorfields Eye Hospital, UCL Institute of Ophthalmology and Topcon Healthcare, Inc. launch Cascader Limited to advance AI-driven eyecare and Oculomics

9 May 2025 | AI, Artificial intelligence, oculomics, news, Moorfields, Cascader, imaging, industry news
Moorfields Eye Hospital NHS Foundation Trust, the UCL Institute of Ophthalmology (IoO), and Topcon Healthcare today announced the launch of Cascader Limited, a new medical technology company that aims to transform the detection and management of eye disease through artificial...

What's trending Feb/Mar 2025

4 February 2025 | | EYE - Cornea, EYE - Neuro-ophthalmology, EYE - Paediatrics, EYE - Vitreo-Retinal
A round-up of the eye-related hot topics that have been trending on social media over the last few weeks. #ChrisMcCausland #StrictlyWinner “I hope that anybody out there that doesn’t know someone who is blind now has higher expectations of what...

In conversation with Robert MacLaren

2 December 2019 | EYE - Vitreo-Retinal, EYE - General
Professor Robert MacLaren gave the Keeler Lecture at the Royal College of Ophthalmologists Annual Meeting in May 2019 on gene therapy for retinitis pigmentosa. We caught up with him afterwards to find out more. What are the key messages of...

World ROP Congress 2025

4 December 2025 -5 December 2025
The World Retinopathy of Prematurity (ROP) Congress 2025

Towards virtual reality conferences?

5 August 2020 | | EYE - General
COVID-19 is forcing us to reconsider every aspect of life. The authors ask what future ophthalmic meetings could look like. The coronavirus disease COVID-19 pandemic disrupted ophthalmic conferences resulting in the cancellation of the majority of meetings in 2020, e.g....